| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Silvia Messina, Romina Mariano, Ruth Geraldes, Su-Hyun Kim, Chanjira Satukijcha, Domizia Vecchio, Yi Yi Chua, James Taylor, Naveen George, Ana Cavey, Alejandro Rubio Diaz, Sandra Reeve, Rosie Everett, Gabriele De Luca, Maria Isabel Leite, Ho Jin Kim, Jacqueline Palac. The influence of smoking on the pattern of disability and relapse risk in AQP4-positive Neuromyelitis Optica Spectrum Disorder, MOG-Ab Disease and Multiple Sclerosis. Multiple sclerosis and related disorders. vol 49. 2021-05-14. PMID:33540279. |
to assess the effect of smoking on relapses and disability in neuromyelitis optica with aquaporin-4-antibodies (nmosd-aqp4-ab), myelin oligodendrocyte glycoprotein-antibodies associated disease (mogad) and relapsing remitting multiple sclerosis (ms) patients. |
2021-05-14 |
2023-08-13 |
Not clear |
| Álvaro Cobo-Calvo, Hyacintha d'Indy, Anne Ruiz, Nicolas Collongues, Laurent Kremer, Françoise Durand-Dubief, Fabien Rollot, Romain Casey, Sandra Vukusic, Jérôme De Seze, Romain Marignie. Frequency of myelin oligodendrocyte glycoprotein antibody in multiple sclerosis: A multicenter cross-sectional study. Neurology(R) neuroimmunology & neuroinflammation. vol 7. issue 2. 2021-05-06. PMID:31836640. |
frequency of myelin oligodendrocyte glycoprotein antibody in multiple sclerosis: a multicenter cross-sectional study. |
2021-05-06 |
2023-08-13 |
Not clear |
| Haley E Titus, Yanan Chen, Joseph R Podojil, Andrew P Robinson, Roumen Balabanov, Brian Popko, Stephen D Mille. Pre-clinical and Clinical Implications of "Inside-Out" vs. "Outside-In" Paradigms in Multiple Sclerosis Etiopathogenesis. Frontiers in cellular neuroscience. vol 14. 2021-05-04. PMID:33192332. |
multiple sclerosis (ms) is an immune-mediated neurological disorder, characterized by central nervous system (cns) inflammation, oligodendrocyte loss, demyelination, and axonal degeneration. |
2021-05-04 |
2023-08-13 |
Not clear |
| Suyog Pol, Serena Liang, Ferdinand Schweser, Ravendra Dhanraj, Anna Schubart, Marilena Preda, Michele Sveinsson, Deepa P Ramasamy, Michael G Dwyer, Gisbert Weckbecker, Robert Zivadino. Subcutaneous anti-CD20 antibody treatment delays gray matter atrophy in human myelin oligodendrocyte glycoprotein-induced EAE mice. Experimental neurology. vol 335. 2021-04-19. PMID:32991933. |
the human myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis (humog-eae) model, generates b-cell driven demyelination in mice, making it a suitable multiple sclerosis model to study b cell depletion. |
2021-04-19 |
2023-08-13 |
mouse |
| John R Ciotti, Noah S Eby, Matthew R Brier, Gregory F Wu, Salim Chahin, Anne H Cross, Robert T Naismit. Central vein sign and other radiographic features distinguishing myelin oligodendrocyte glycoprotein antibody disease from multiple sclerosis and aquaporin-4 antibody-positive neuromyelitis optica. Multiple sclerosis (Houndmills, Basingstoke, England). 2021-04-19. PMID:33870786. |
central vein sign and other radiographic features distinguishing myelin oligodendrocyte glycoprotein antibody disease from multiple sclerosis and aquaporin-4 antibody-positive neuromyelitis optica. |
2021-04-19 |
2023-08-13 |
Not clear |
| John R Ciotti, Noah S Eby, Matthew R Brier, Gregory F Wu, Salim Chahin, Anne H Cross, Robert T Naismit. Central vein sign and other radiographic features distinguishing myelin oligodendrocyte glycoprotein antibody disease from multiple sclerosis and aquaporin-4 antibody-positive neuromyelitis optica. Multiple sclerosis (Houndmills, Basingstoke, England). 2021-04-19. PMID:33870786. |
myelin oligodendrocyte glycoprotein antibody disease (mogad) can radiographically mimic multiple sclerosis (ms) and aquaporin-4 (aqp4) antibody-positive neuromyelitis optica spectrum disorder (nmosd). |
2021-04-19 |
2023-08-13 |
Not clear |
| Sven Jarius, Brigitte Wildeman. [Aquaporin 4 antibody-positive neuromyelitis optica spectrum disorders and myelin oligodendrocyte glycoprotein antibody-associated encephalomyelitis. A brief review]. Der Nervenarzt. vol 92. issue 4. 2021-04-09. PMID:33787942. |
aquaporin 4 (aqp4) immunoglobulin (ig)g-associated neuromyelitis optica spectrum disorders (nmosd) and myelin oligodendrocyte glycoprotein immunoglobulin (ig)g-associated encephalomyelitis (mog-em, also termed mog antibody-associated disease, mogad) are important autoimmune differential diagnoses of multiple sclerosis (ms), which differ from ms with respect to optimum treatment and prognosis. |
2021-04-09 |
2023-08-13 |
Not clear |
| Sabah Mozafari, Laura Starost, Blandine Manot-Saillet, Beatriz Garcia-Diaz, Yu Kang T Xu, Delphine Roussel, Marion J F Levy, Linda Ottoboni, Kee-Pyo Kim, Hans R Schöler, Timothy E Kennedy, Jack P Antel, Gianvito Martino, Maria Cecilia Angulo, Tanja Kuhlmann, Anne Baron-Van Evercoore. Multiple sclerosis iPS-derived oligodendroglia conserve their properties to functionally interact with axons and glia in vivo. Science advances. vol 6. issue 49. 2021-03-17. PMID:33277253. |
multiple sclerosis ips-derived oligodendroglia conserve their properties to functionally interact with axons and glia in vivo. |
2021-03-17 |
2023-08-13 |
mouse |
| Sabah Mozafari, Laura Starost, Blandine Manot-Saillet, Beatriz Garcia-Diaz, Yu Kang T Xu, Delphine Roussel, Marion J F Levy, Linda Ottoboni, Kee-Pyo Kim, Hans R Schöler, Timothy E Kennedy, Jack P Antel, Gianvito Martino, Maria Cecilia Angulo, Tanja Kuhlmann, Anne Baron-Van Evercoore. Multiple sclerosis iPS-derived oligodendroglia conserve their properties to functionally interact with axons and glia in vivo. Science advances. vol 6. issue 49. 2021-03-17. PMID:33277253. |
remyelination failure in multiple sclerosis (ms) is associated with a migration/differentiation block of oligodendroglia. |
2021-03-17 |
2023-08-13 |
mouse |
| Matthias Baumann, Frederik Bartels, Carsten Finke, Catherine Adamsbaum, Yael Hacohen, Kevin Rostás. E.U. paediatric MOG consortium consensus: Part 2 - Neuroimaging features of paediatric myelin oligodendrocyte glycoprotein antibody-associated disorders. European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society. vol 29. 2021-03-15. PMID:33158737. |
imaging plays a crucial role in differentiating the spectrum of paediatric acquired demyelinating syndromes (ads), which apart from myelin oligodendrocyte glycoprotein antibody associated disorders (mogad) includes paediatric multiple sclerosis (ms), aquaporin-4 antibody neuromyelitis optica spectrum disorders (nmosd) and unclassified patients with both monophasic and relapsing ads. |
2021-03-15 |
2023-08-13 |
Not clear |
| Yaqin Sun, Jing Ji, Zheng Zha, Hui Zhao, Bing Xue, Liangyun Jin, Lei Wan. Effect and Mechanism of Catalpol on Remyelination via Regulation of the NOTCH1 Signaling Pathway. Frontiers in pharmacology. vol 12. 2021-03-13. PMID:33708131. |
promoting the differentiation of oligodendrocyte precursor cells (opcs) is important for fostering remyelination in multiple sclerosis. |
2021-03-13 |
2023-08-13 |
Not clear |
| Nidhi Sharma, Ambika Shandilya, Nitish Kumar, Sidharth Meha. Dysregulation of SIRT-1 Signaling in Multiple Sclerosis and Neuroimmune Disorders: A Systematic Review on SIRTUIN Activators as Potential Immunomodulators and Influences on other Dysfunctions. Endocrine, metabolic & immune disorders drug targets. 2021-03-10. PMID:33687904. |
immune dysregulation, neuronal inflammation, and oligodendrocyte degradation are key causes for autoimmune disorders like multiple sclerosis (ms) and various otherimmune dysregulated neurodegenerative complications responsible for cns-mediated immune responses.sirtuins (sirt-1) is nicotinamide adenosine dinucleotide (nad)-dependent transcriptional protein thatdeacetylases and removes acetyl groups from its transcription factors like p53, foxo, nf-Κb, pgc-1α. |
2021-03-10 |
2023-08-13 |
Not clear |
| Sakie Miyamura, Nagisa Matsuo, Kazuki Nagayasu, Hisashi Shirakawa, Shuji Kanek. Myelin Oligodendrocyte Glycoprotein 35-55 (MOG 35-55)-induced Experimental Autoimmune Encephalomyelitis: A Model of Chronic Multiple Sclerosis. Bio-protocol. vol 9. issue 24. 2021-03-05. PMID:33654948. |
myelin oligodendrocyte glycoprotein 35-55 (mog 35-55)-induced experimental autoimmune encephalomyelitis: a model of chronic multiple sclerosis. |
2021-03-05 |
2023-08-13 |
mouse |
| Marina Boziki, Styliani-Aggeliki Sintila, Panagiotis Ioannidis, Nikolaos Grigoriadi. Biomarkers in Rare Demyelinating Disease of the Central Nervous System. International journal of molecular sciences. vol 21. issue 21. 2021-03-02. PMID:33182495. |
multiple sclerosis (ms) needs to be differentially diagnosed from rare ms variants, acute disseminated encephalomyelitis (adem), the range of neuromyelitis optica spectrum disorders (nmosds), myelin oligodendrocyte glycoprotein (mog) antibody disease and other systemic inflammatory diseases. |
2021-03-02 |
2023-08-13 |
Not clear |
| Ward Doelman, Mikkel H S Marqvorsen, Fabrizio Chiodo, Sven C M Bruijns, Gijsbert A van der Marel, Yvette van Kooyk, Sander I van Kasteren, Can Arama. Synthesis of Asparagine Derivatives Harboring a Lewis X Type DC-SIGN Ligand and Evaluation of their Impact on Immunomodulation in Multiple Sclerosis. Chemistry (Weinheim an der Bergstrasse, Germany). vol 27. issue 8. 2021-03-01. PMID:33090600. |
the protein myelin oligodendrocyte glycoprotein (mog) is a key component of myelin and an autoantigen in the disease multiple sclerosis (ms). |
2021-03-01 |
2023-08-13 |
Not clear |
| Sonsoles Barriola, Fernando Pérez-Cerdá, Carlos Matute, Ana Bribián, Laura López-Mascaraqu. A Clonal NG2-Glia Cell Response in a Mouse Model of Multiple Sclerosis. Cells. vol 9. issue 5. 2021-02-25. PMID:32455842. |
ng2-glia, also known as oligodendrocyte precursor cells (opcs), have the potential to generate new mature oligodendrocytes and thus, to contribute to tissue repair in demyelinating diseases like multiple sclerosis (ms). |
2021-02-25 |
2023-08-13 |
mouse |
| Maria-Eleni Androutsou, Agathi Nteli, Areti Gkika, Maria Avloniti, Anastasia Dagkonaki, Lesley Probert, Theodore Tselios, Simona Golič Grdadolni. Characterization of Asparagine Deamidation in Immunodominant Myelin Oligodendrocyte Glycoprotein Peptide Potential Immunotherapy for the Treatment of Multiple Sclerosis. International journal of molecular sciences. vol 21. issue 20. 2021-02-25. PMID:33066323. |
characterization of asparagine deamidation in immunodominant myelin oligodendrocyte glycoprotein peptide potential immunotherapy for the treatment of multiple sclerosis. |
2021-02-25 |
2023-08-13 |
Not clear |
| Berin Inan, Rahsan Gocmen, Atay Vural, Ayse Ilksen Colpak, Edgar Meinl, Rana Karabudak, Asli Tunce. Corrigendum to Myelin Oligodendrocyte Glycoprotein Antibody Associated Central Nervous System Demyelinating Disease: A Tertiary Center Experience From Turkey [Multiple Sclerosis and Related Disorders 44 (2020) 102376]. Multiple sclerosis and related disorders. vol 48. 2021-02-17. PMID:33593587. |
corrigendum to myelin oligodendrocyte glycoprotein antibody associated central nervous system demyelinating disease: a tertiary center experience from turkey [multiple sclerosis and related disorders 44 (2020) 102376]. |
2021-02-17 |
2023-08-13 |
Not clear |
| Davide Lecca, Maria P Abbracchio, Marta Fumagall. Purinergic Receptors on Oligodendrocyte Progenitors: Promising Targets for Myelin Repair in Multiple Sclerosis? Frontiers in pharmacology. vol 11. 2021-02-16. PMID:33584312. |
purinergic receptors on oligodendrocyte progenitors: promising targets for myelin repair in multiple sclerosis? |
2021-02-16 |
2023-08-13 |
Not clear |
| M J Wendebourg, S Nagy, T Derfuss, K Parmar, R Schlaege. Magnetic resonance imaging in immune-mediated myelopathies. Journal of neurology. vol 267. issue 5. 2021-02-08. PMID:30694379. |
aquaporin-4 igg channelopathy or anti-myelin oligodendrocyte glycoprotein-associated myelitis, myelopathies in the context of multiple sclerosis and systemic autoimmune disorders with myelopathy, as well as post-infectious and paraneoplastic myelopathies. |
2021-02-08 |
2023-08-13 |
Not clear |